Abstract
Cannabis, particularly as smoked as marijuana cigarettes (“joint,” “reefer,” “herb”), is the most frequently abused illicit substance in the United States. Not surprisingly, psychologists and other mental professionals are asked to evaluate large numbers of often youthful people with psychiatric and behavioral problems who also use cannabis. In some individuals, the cannabis use clearly leads to the psychological and psychiatric consequences observed by the clinician. In others, the psychopathology noted antedates the cannabis use or dependence and is a determinate of drug use. Both the drug use and the psychopathology may also occur concurrently and be relatively independent of each other. Further complicating the picture, other illicit drugs and alcohol are often used in association with cannabis. The intermittent or occasional use of cannabis may not be associated with any psychological or psychiatric consequences.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alcoholism and Drug Addiction Research Foundation/World Health Organization. (1981). Report of an ARF/WHO Scientific Meeting on Adverse Health and Behavioral Consequences of Cannabis Use. Toronto, Ontario, Canada: Author.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders ( 4th ed. ). Washington, DC: Author.
Ames, E. (1958). A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses. Journal of Mental Science, 104, 972–999.
Andreasson, S., Allenbeck, P., & Rydberg, U. (1989). Schizophrenia in users and non-users of cannabis: A longitudinal study in Stockholm county. Acta Psychiatrica Scandinavica, 79, 505–510.
Beaubrun, M., & Knight, E (1973). Psychiatric assessment of 30 chronic users of cannabis and 30 matched controls. American Journal of Psychiatry, 130, 309–311.
Beeder, A. B., & Millman, R. B. (1992). Treatment of patients with psychopathology and substance abuse. In J. H. Lowinson, P. Ruiz, R. B. Millman, & John Langrod (Eds.), Substance abuse: A comprehensive textbook ( 2nd ed., pp. 675–690 ). Baltimore: Williams & Wilkins.
Bernhardson, G., & Gunne, L. M. (1972). Forty-six cases of psychosis in cannabis abusers. International Journal of the Addictions, 7, 9–16.
Brady, J. V., Foltin, R. W, Fischman. M. W., & Capriotti, R. M. (1986). Behavioral interactions and the effects of marijuana. Alcohol, Drugs, and Driving, 2, 93–103.
Breier, A., Buchanan, R. W., Kirkpatrick, B., Davis, O. R., Irish, D., Summerfelt, A., & Carpenter, W. T. (1994). Effects of Clozapine on positive and negative symptoms in outpatients with schizophrenia. American Journal of Psychiatry, 151, 20–26.
Brill, H., & Nahas, G. G. (1984). Cannabis intoxication and mental illness. In G. G. Nahas (Ed.), Marijuana in science and medicine (pp. 263–305 ). New York: Raven.
Carter, W. E. (1980). Cannabis in Costa Rica: A study of chronic marijuana use. Philadelphia: Institute for the Study of Human Issues.
Chaudry, H. R., Moss, H. B., Bashir, A., & Suliman, T. (1991). Cannabis psychosis following bhang ingestion. British Journal of Addiction, 86, 1075–1081.
Chopra, G., & Smith, J. (1974). Psychotic reactions following cannabis use in East Indians. Archives of General Psychiatry, 30, 24–27.
Clayton, R. R., & Voss, H. L. (1981). Young men and drugs in Manhattan: A casual analysis (NIDA Research Monograph No. 39 ). Washington, DC: U.S. Government Printing Office.
Edwards, G. (1983). Psychopathology of a drug experience. British Journal of Psychiatry, 143, 509–512.
Ellis, G. M., Mann, M. A., Judson, B. A., Schramm, N. T., & Taschian, A. (1985). Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clinical Pharmacology Therapeutics, 38, 572–578.
Estroff, T. W. & Gold, M. S. (1986). Psychiatric presentations of marijuana abuse. Psychiatric Annals, 16, 221–224.
Ghodse, H. (1986). Cannabis psychosis. British Journal of Addiction, 81, 473–478.
Grinspoon, L., & Bakalar, J. B. (1986). Psychedelics and arylcyclohexylamines. In A. J. Frances & R. E. Hales (Eds.), Psychiatry update: American Psychiatric Association annual review (Vol. 5, pp. 212–225 ). Washington, DC: American Psychiatric Press.
Hall, W., Solowij, N., & Lemon, J. (1994). The health and psychological effects of cannabis (National Drug Strategy Monograph No. 25 ). Canberra, Australia: Australian Government Publishing Service.
Hammer, T. (1990). Per Vaglum: Initiation, continuation, or discontinuation of cannabis use in the general population. British Journal ofAddiction, 85, 899–909.
Harding, T., & Knight, F. (1973). Marijuana-modified mania. Archives of General Psychiatry, 29, 635–637.
Hunt, C. A., & Jones, R. T. (1980). Tolerance and disposition of tetrahydrocannabinol in man. Journal of Pharmacology and Experimental Therapeutics, 215, 35–44.
Jessor, R. (1975). Predicting time of marijuana use: A developmental study of high school youths. In D. J. Lettieri (Ed.), Predicting adolescent drug abuse: A review of issues, methods, and correlates: Research issues, 11. Rockville, MD: National Institute on Drug Abuse.
Jessor, R.. & Jessor, S. L. (1977). Problem behavior and psychosocial development: A longitudinal stuck of youth. New York: Academic Press.
Jessor, R., Chase, J. A., & Donovan, J. E. (1980). Psychosocial correlates of marijuana use and problem drinking in a national sample of adolescents. American Journal of Public Health, 70, 604–613.
Jessor, R., Donovan, J., & Costa, E (1986). Psychoactive correlates of marijuana in adolescent and young adulthood: The past as prologue, in marijuana, cocaine, and traffic society. In H. Moskowitz (Ed.), Alcohol, drugs and driving (Vol. 2, pp. 31–49 ). Santa Monica, CA.
Johansson, E., Agurell, S., Hollister, L. E., & Halldin, M. M. (1988). Prolonged apparent half-life of delta-l-tetrahydrocannabinol in plasma of chronic marijuana users. Journal of Pharmacy and Pharmacology, 40, 374–375.
Johnson, B. A. (1990). Psychopharmacological effects of cannabis. British Journal of Hospital Medicine, 43, 114–122.
Jones, R. T., & Benowitz, N. (1976). The 30-day trip-Clinical studies of cannabis tolerance and dependence. In M. C. Braude & S. Szara (Eds.), The pharmacology of marijuana (pp. 627–642 ). New York: Raven.
Jones, R. T., Benowitz, N., & Bachman, J. (1976). Clinical studies of cannabis tolerance and dependence. Annals of the New York Academy of Sciences, 282, 221–239.
Jones, R. T., Benowitz, N. L., & Fleming, R. I. (1981). Clinical relevance of cannabis tolerance and dependence. Journal of Clinical Pharmacology, 21 (Suppl.), 143S - I52S.
Kandel, D. B. (Ed). (1978). Longitudinal research on drug use: Empirical. findings and methodological issues. Washington, DC: Hemisphere.
Kandel, D. B., & Davies, M. (1992). Progression to regular marijuana involvement: Phenomenology and risk factors for near-daily use. In M. Glantz & R. Pickens (Eds.), Vulnerability to drug abuse (pp. 211–254 ). Washington, DC: American Psychological Association.
Kandel, D. B., Kessler, R., & Margulies, R. (1978). Antecedents of adolescent initiation into stages of drug use: A developmental analysis. In D. B. Kandel (Ed.), Longitudinal research on drug use: Empirical findings and methodological issues (pp. 73–99 ). Washington, DC: Hemisphere.
Keup, W. (1970). Psychotic symptoms due to cannabis abuse. Diseases of the Nervous System, 31, 119–126.
Khantzian, E. J., & McKenna, G. J. (1979). Acute toxic and withdrawal reactions associated with drug use and abuse. Annals of Internal Medicine, 90, 361–373.
Kiplinger, G. G., & Manno, J. E. (1971). Dose response relationships to cannabis in human subjects. Pharmacological Review, 23, 339–347.
Knight, F. (1976). Role of cannabis in psychiatric disturbance. Annals of the New York Academy of Sciences, 282, 64–71.
Knudsen, P., & Vilmar, T. (1984). Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatrica Scandinavica, 69, 162–174.
Kouri, E., Pope, H. G., Yurgelun-Todd, D., & Gruber, S. (1995). Attributes of heavy vs. occasional marijuana smokers in a college population. Biological Psychiatry. 38, 475–481.
Lex, B. W., Griffin, M. L., Mello, N. K., & Mendelson, J. (1989). Alcohol, marijuana and mood states in young women. International Journal of the Addictions, 24, 405–424.
Marder, S. R., & Meibach, R. C. (1994). Risperidone in the treatment of schizophrenia. American Journal of Psychiatry, 151, 825–835.
Marlotte, D. B. (1972). Marijuana and mutism. American Journal of Psychiatry, 129, 475–477.
Mathers, D. C., Ghodse, A. H., Cann, A. W., & Scott, S. A. (1991). Cannabis use in a large sample of acute psychiatric admissions. British Journal of Addiction, 86, 779–784.
McLellan, A. T., Woody, G. E., & O’Brien, C. P. (1979). Development of psychiatric illness in drug abusers: Possible role of drug preference. New England Journal of Medicine, 301, 1310–1314.
Mendelson, J. H., Mello, N. K., Lex, B. W., & Bavli, S. (1984). Marijuana withdrawal syndrome in a woman. American Journal of Psychiatry, 141, 1289–1290.
Mendhiratta, S. S., Varma, V. K., Dang, R., Malhotra, A. K., Das, K., & Nehra, R. (1988). Cannabis and cognitive functions: A re-evaluation study. British Journal ofAddictions, 20, 57–65.
Millman, R. B., & Beeder. A. B. (1994). Treatment of patients for specific drugs of abuse: Cannabis. In M. Galanter & H. D. Kleber (Eds.), The American Psychiatric Press textbook of substance abuse treatment (pp. 91–109 ). Washington, DC: American Psychiatric Press.
Millman, R. B., & Sbriglio, R. (1986). Patterns of use and psychopathology in chronic marijuana users. Psychiatric Clinics of North America, 9, 533–545.
Musty, R. E., & Kaback, L. (1995). Relationships between motivation and depression in chronic marijuana users. Life Sciences, 56, 2151–2158.
National Institute on Drug Abuse. (1995). The monitoring the future study, Institute for Social Research. Ann Arbor: University of Michigan Press.
Negrete, J. C. (1988). What’s happened to the cannabis de- bate? British Journal of Addiction, 83, 359–372.
Nicholi, A. A. (1983). The non-therapeutic use of psychoactive drugs: A modern epidemic. New England Journal of Medicine, 308, 925–933.
O’Connell, D. E (1990). Managing the dually diagnosed patient. In D. F. O’Connell (Ed.), Current issues and clinical approaches. New York: Haworth.
O’Donnell, J. A., & Clayton, R. R. (1979). The stepping stone hypothesis: A reappraisal. In G. M. Beschner & A. S. Friedman (Eds.), Youth drug abuse: Problems, issues and treatment. Lexington, MA: Lexington Books.
O’Donnell, J. A., Voss, H. L., Clayton, R. R., Slatin, G. T., & Room, R. G. (1976). Young men and drugs: A nationwide survey (NIDA Research Monograph No. 5; DHEW Publication No. ADM-76–311). Washington, DC: U.S. Government Printing Office.
O’Malley, P. M., Johnston, L. D., & Bachman, J. G. (1985). Cocaine use among American adolescents and young adults. In N. J. Kozel & E. H. Adams (Eds.), Cocaine use in America: Epidemiologic and clinical perspectives (NIDA Research Monograph No. 61, pp. 50–75 ). Washington, DC: National Institute on Drug Abuse.
Palsson, A., Thulin, S. O., & Tunving, K. (1982). Cannabis psychosis in South Sweden. Acta Psychiatrica Scandinavica, 66, 311–321.
Pope, H. G., & Yurgelun-Todd, D. (1996). The residual cognitive effects of heavy marijuana use in college students. Journal of the American Medical Association, 7, 521–527.
Pope, H. G., Gruber, A. J., & Yurgelun-Todd, D. (1995). The residual neuropsychological effects of cannabis: The current status of research. Drug and Alcohol Dependence, 38, 25–34.
Rohr, J. M., Showlund, S. W, & Martin, T. E. (1989). Withdrawal sequelae to cannabis use. International Journal of the Addictions, 14, 627–631.
Rubin V, & Comitas, L. (1975). Psychological assessment. In V. Rubin & L. Comitas (Eds.), Ganja in Jamaica: A medical-anthropological study of chronic marijuana use (pp. 111–119 ). The Hague, Netherlands: Mouton.
Rubin, V., & Comitas, L. (1976). Ganja in Jamaica: The effects of marijuana. New York: Anchor/Doubleday.
Schwartz, R. H., Gruenwald, E J., Klitzner, M., & Fedio, P. (1989). Short-term memory impairment in cannabis-dependent adolescents. American Journal of Diseases of Children, 143, 1214–1219.
Seth, R., & Sinha, S. (1991). Chemistry and pharmacology of cannabis. Progress in Drug Research, 36, 71–115.
Smith, D. E. (1968). Acute and chronic toxicity of mari- juana. Journal of Psychedelic Drugs, 2, 37–47.
Solomons, K., & Neppe, V. M. (1989). Cannabis-Its clinical effects. South African Medical Journal, 76, 102–104.
Stefanis, C., Boulougouris. I., & Liakos, A. (1976). Clinical and psychophysiological effects of cannabis in long-term users. In M. C. Brause & S. Szara (Eds.), Pharmacology of marijuana. New York: Raven.
Substance Abuse and Mental Health Services Administration. (1995). Preliminary estimates fions the 1994 National Household Survey on Drug Abuse, Advance Report No. 10. Washington, DC: U.S. Government Printing Office.
Thomicroft, G. (1990). Cannabis and psychosis-Is there epidemiological evidence for an association? British Journal of Psychiatry, 157, 25–33.
Tien, A. Y., & Anthony, J. C. (1990). Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. Journal of Nervous and Mental Disease, 178, 473–480.
Tunving, K. (1985). Psychiatric effects of cannabis use. Acta Psychiatrica Scandinavica, 72, 209–217.
Wall, M. E., & Perez-Reyes, M. (1981). The metabolism of delta-9-tetrahydrocannabinol and related cannabinoids in man. Journal of Clinical Pharmacology, 21, 1785–1795.
Zablocki, B., Aidala, A., Hansell, S., & White, H. R. (1991). Marijuana use, introspectiveness, and mental health. Journal of Health and Social Behavior, 32, 65–79.
Zinberg, N. (1984). Drug, set and setting. New Haven, CT: Yale University Press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Phariss, B., Millman, R.B., Beeder, A.B. (1998). Psychological and Psychiatric Consequences of Cannabis. In: Tarter, R.E., Ammerman, R.T., Ott, P.J. (eds) Handbook of Substance Abuse. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2913-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2913-9_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3297-6
Online ISBN: 978-1-4757-2913-9
eBook Packages: Springer Book Archive